Mass General Brigham’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.37M Hold
68,413
– – 0.52% 8
2026
Q2
$2.7M Sell
68,413
-1,944
-3% -$78.3K 0.75% 6
2026
Q1
$3.13M Buy
70,357
+44,063
+168% +$1.95M 0.67% 6
2025
Q4
$1.1M Buy
+26,294
New +$1.11M 0.14% 6

Other funds holding MDLN

Mass General Brigham's MDLN Position: Q3 2026 in Review

Mass General Brigham held its Medline (MDLN) position steady in Q3 2026 at 68,413 shares worth $2.37M. The position accounts for 0.52% of the portfolio, ranked #8.

Mass General Brigham first reported a position in MDLN in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.13M in Q1 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Mass General Brigham held 68,413 shares of Medline worth $2.37M as of Q3 2026.
  • Mass General Brigham left its Medline share count unchanged in Q3 2026.
  • Medline made up 0.52% of Mass General Brigham's portfolio in Q3 2026, its #8 holding.
  • Mass General Brigham first reported a position in Medline in Q4 2025 and has held it in 4 quarters since.
  • Mass General Brigham's Medline position peaked at $3.13M in Q1 2026.
  • 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on Mass General Brigham's 13F filing for Q3 2026, filed 3 Nov 2026.